Loading…
K M C Speciality Hospitals (India) (BSE 524520)₹156.35−1.01%Hospital
At the end of the Jun 2026 quarter, K M C Speciality Hospitals (India)'s shareholders were: promoters 74.96%, FIIs 0.02%, public 25.02%. Promoter holding is unchanged on the quarter. FII holding is up 0.02 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 88,524 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% | 74.96% |
| FIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% | 0.02% |
| Public | 25.04% | 25.04% | 25.04% | 25.04% | 25.04% | 25.04% | 25.03% | 25.04% | 25.04% | 25.04% | 25.04% | 25.02% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 82,001 | 81,473 | 86,364 | 87,837 | 87,648 | 87,912 | 88,046 | 87,288 | 86,994 | 86,380 | 86,354 | 88,524 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Sri Kauvery Medical Care (India) Limited | Promoter | 75.04% | New |
| D Chitra | Public | 1.35% | 0.00 |
| Anitha S | Public | 1.14% | 0.00 |
| Sri Kauvery Medical Care (India)Limited | Promoter | Exited | — |
Promoters held 74.96% of K M C Speciality Hospitals (India) at the end of the Jun 2026 quarter, the same as a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 0.02% (up 0.02 percentage points from 0.00% a quarter earlier) and domestic institutions (DIIs) held no reported stake.
No. The Jun 2026 filing shows no pledged promoter shares.
K M C Speciality Hospitals (India) had 88,524 shareholders at the end of the Jun 2026 quarter, against 87,288 a year earlier.
D Chitra (Public) held 1.35% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.